Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.

Hegde SS, Difuntorum S, Skinner R, Trumbull J, Krause KM.

J Antimicrob Chemother. 2009 Apr;63(4):763-6. doi: 10.1093/jac/dkp001. Epub 2009 Jan 20.

PMID:
19155225
2.

In vitro activity of telavancin against resistant gram-positive bacteria.

Krause KM, Renelli M, Difuntorum S, Wu TX, Debabov DV, Benton BM.

Antimicrob Agents Chemother. 2008 Jul;52(7):2647-52. doi: 10.1128/AAC.01398-07. Epub 2008 Apr 28.

3.

Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus.

Hegde SS, Reyes N, Skinner R, Difuntorum S.

J Antimicrob Chemother. 2008 Jan;61(1):169-72. Epub 2007 Nov 9.

PMID:
17993505
4.

DNA binding ligands with improved in vitro and in vivo potency against drug-resistant Staphylococcus aureus.

Hu W, Bürli RW, Kaizerman JA, Johnson KW, Gross MI, Iwamoto M, Jones P, Lofland D, Difuntorum S, Chen H, Bozdogan B, Appelbaum PC, Moser HE.

J Med Chem. 2004 Aug 26;47(18):4352-5.

PMID:
15317448
5.

DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 2: C-terminal benzimidazoles and derivatives.

Bürli RW, Jones P, McMinn D, Le Q, Duan JX, Kaizerman JA, Difuntorum S, Moser HE.

Bioorg Med Chem Lett. 2004 Mar 8;14(5):1259-63.

PMID:
14980677
6.

In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.

Lofland D, Difuntorum S, Waller A, Clements JM, Weaver MK, Karlowsky JA, Johnson K.

J Antimicrob Chemother. 2004 Apr;53(4):664-8. Epub 2004 Feb 18.

PMID:
14973152
7.

Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.

Gross M, Clements J, Beckett RP, Thomas W, Taylor S, Lofland D, Ramanathan-Girish S, Garcia M, Difuntorum S, Hoch U, Chen H, Johnson KW.

J Antimicrob Chemother. 2004 Mar;53(3):487-93. Epub 2004 Feb 12.

PMID:
14963065
8.

In vitro antimicrobial activity of GSQ1530, a new heteroaromatic polycyclic compound.

Ge Y, Difuntorum S, Touami S, Critchley I, Bürli R, Jiang V, Drazan K, Moser H.

Antimicrob Agents Chemother. 2002 Oct;46(10):3168-74.

Supplemental Content

Loading ...
Support Center